Isopaque 440 (metrizoate); a new cardiovascular contrast medium. Experience with 100 consecutive cases.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000790:Angiocardiography; D001027:Aortography; D005117:Cardiac Complexes, Premature / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D003287:Contrast Media / Q000009:adverse effects*; D004342:Drug Hypersensitivity; D004562:Electrocardiography; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D013610:Tachycardia / Q000139:chemically induced; D014581:Urticaria / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D003287:Contrast Media